The cellular redox environment alters antigen presentation

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27979-27991

  Trujillo, Jonathan A ^a   Croft, Nathan P ^b,c   Dudek, Nadine L ^b,c   Channappanavar, Rudragouda ^a   Theodossis, Alex ^c   Webb, Andrew I ^b   Dunstone, Michelle A ^c   Illing, Patricia T ^b   Butler, Noah S ^a,d,f   Fett, Craig ^a   Tscharke, David C ^c   Rossjohn, Jamie ^c,e   Perlman, Stanley ^a   Purcell, Anthony W ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CYTOLOGY; EPITOPES; PLANTS (BOTANY); T-CELLS; VIRUSES;

ANTIGEN PRESENTATION; COVALENT LINKAGE; CYSTEINE RESIDUES; CYSTEINE-CONTAINING PEPTIDES; STRUCTURAL BASIS; T CELL RECOGNITION; T-CELL EPITOPES; VIRAL INFECTIONS;

PEPTIDES;

CYSTEINE; CYSTEINE CONTAINING PEPTIDE; EPITOPE; GLUTATHIONE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; COVALENT BOND; DATA BASE; FEMALE; IMMUNE SYSTEM; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN MODIFICATION; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; BRAIN; C57BL MOUSE; CD8+ T LYMPHOCYTE; CORONAVIRUS INFECTION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MURINE HEPATITIS CORONAVIRUS; OXIDATION REDUCTION REACTION; RODENT DISEASE; VETERINARY; VIROLOGY;

ANIMALS; ANTIGEN PRESENTATION; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CORONAVIRUS INFECTIONS; CYSTEINE; EPITOPES, T-LYMPHOCYTE; FEMALE; GLUTATHIONE; MALE; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; OXIDATION-REDUCTION; RODENT DISEASES;

EID: 84907612606     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.573402     Document Type: Article

References (79)

1. Dudek, N. L., Tan, C. T., Gorasia, D. G., Croft, N. P., Illing, P. T., and Purcell, A. W. (2012) Constitutive and inflammatory immunopeptidome of pancreatic beta-cells. Diabetes 61, 3018-3025
2. Scull, K. E., Dudek, N. L., Corbett, A. J., Ramarathinam, S. H., Gorasia, D. G., Williamson, N. A., and Purcell, A. W. (2012) Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A∗02:01 ligands. Mol. Immunol. 51, 136-142
3. Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., and Willcox, B. E. (2008) Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat. Immunol. 9, 1236-1243
4. Petersen, J., Wurzbacher, S. J., Williamson, N. A., Ramarathinam, S. H., Reid, H. H., Nair, A. K., Zhao, A. Y., Nastovska, R., Rudge, G., Rossjohn, J., and Purcell, A. W. (2009) Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumorspecific epitopes. Proc. Natl. Acad. Sci. U.S.A. 106, 2776-2781
5. Zarling, A. L., Polefrone, J. M., Evans, A. M., Mikesh, L. M., Shabanowitz, J., Lewis, S. T., Engelhard, V. H., and Hunt, D. F. (2006) Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 103, 14889-14894
6. Depontieu, F. R., Qian, J., Zarling, A. L., McMiller, T. L., Salay, T. M., Norris, A., English, A. M., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Topalian, S. L. (2009) Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 106, 12073-12078
7. Petersen, J., Purcell, A. W., and Rossjohn, J. (2009) Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J. Mol. Med. 87, 1045-1051
8. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., Ohtsuki, M., Furukawa, H., Yoshino, S., Yukioka, M., Tohma, S., Matsubara, T., Wakitani, S., Teshima, R., Nishioka, Y., Sekine, A., Iida, A., Takahashi, A., Tsunoda, T., Nakamura, Y., and Yamamoto, K. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395-402
9. van Venrooij, W. J., van Beers, J. J., and Pruijn, G. J. (2011) Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 391-398
10. Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B., van Heemst, J., Pike, R. N., McCluskey, J., Toes, R. E., La Gruta, N. L., Purcell, A. W., Reid, H. H., Thomas, R., and Rossjohn, J. (2013)Amolecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210, 2569-2582
11. Anderson, R. P., Degano, P., Godkin, A. J., Jewell, D. P., and Hill, A. V. (2000) In vivo antigen challenge in celiac disease identifies a single transglutaminase- modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6, 337-342
12. Henderson, K. N., Tye-Din, J. A., Reid, H. H., Chen, Z., Borg, N. A., Beissbarth, T., Tatham, A., Mannering, S. I., Purcell, A. W., Dudek, N. L., van Heel, D. A., McCluskey, J., Rossjohn, J., and Anderson, R. P. (2007) A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27, 23-34
13. Qiao, S. W., Sollid, L. M., and Blumberg, R. S. (2009) Antigen presentation in celiac disease. Curr. Opin. Immunol. 21, 111-117
14. Broughton, S. E., Petersen, J., Theodossis, A., Scally, S. W., Loh, K. L., Thompson, A., van Bergen, J., Kooy-Winkelaar, Y., Henderson, K. N., Beddoe, T., Tye-Din, J. A., Mannering, S. I., Purcell, A. W., McCluskey, J., Anderson, R. P., Koning, F., Reid, H. H., and Rossjohn, J. (2012) Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity 37, 611-621
15. Petersen, J., Montserrat, V., Mujico, J. R., Loh, K. L., Beringer, D. X., van Lummel, M., Thompson, A., Mearin, M. L., Schweizer, J., Kooy-Winkelaar, Y., van Bergen, J., Drijfhout, J. W., Kan, W. T., La Gruta, N. L., Anderson, R. P., Reid, H. H., Koning, F., and Rossjohn, J. (2014) T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat. Struct. Mol. Biol. 21, 480-488
16. Mannering, S. I., Harrison, L. C., Williamson, N. A., Morris, J. S., Thearle, D. J., Jensen, K. P., Kay, T. W., Rossjohn, J., Falk, B. A., Nepom, G. T., and Purcell, A. W. (2005) The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J. Exp. Med. 202, 1191-1197
17. Mannering, S. I., Pang, S. H., Williamson, N. A., Naselli, G., Reynolds, E. C., O'Brien-Simpson, N. M., Purcell, A. W., and Harrison, L. C. (2009) The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. Clin. Exp. Immunol. 156, 226-231
18. Webb, A. I., Dunstone, M. A., Chen, W., Aguilar, M. I., Chen, Q., Jackson, H., Chang, L., Kjer-Nielsen, L., Beddoe, T., McCluskey, J., Rossjohn, J., and Purcell, A. W. (2004) Functional and structural characteristics of NYESO- 1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. J. Biol. Chem. 279, 23438-23446
19. Purcell, A. W., McCluskey, J., and Rossjohn, J. (2007) More than one reason to rethink the use of peptides in vaccine design. Nat. Rev. Drug Discov. 6, 404-414
20. Ambrose, R. L., and Mackenzie, J. M. (2011) West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion. J. Virol. 85, 2723-2732
21. Burnett, H. F., Audas, T. E., Liang, G., and Lu, R. R. (2012) Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection. Cell Stress Chaperones 17, 473-483
22. DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. A., Alvarez, E., Oliveros, J. C., Zhao, J., Fett, C., Perlman, S., and Enjuanes, L. (2011) Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 7, e1002315
23. Hassan, I. H., Zhang, M. S., Powers, L. S., Shao, J. Q., Baltrusaitis, J., Rutkowski, D. T., Legge, K., and Monick, M. M. (2012) Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway. J. Biol. Chem. 287, 4679-4689
24. Merquiol, E., Uzi, D., Mueller, T., Goldenberg, D., Nahmias, Y., Xavier, R. J., Tirosh, B., and Shibolet, O. (2011) HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response. PLoS One 6, e24660
25. Qian, Z., Xuan, B., Chapa, T. J., Gualberto, N., and Yu, D. (2012) Murine cytomegalovirus targets transcription factor ATF4 to exploit the unfoldedprotein response. J. Virol. 86, 6712-6723
26. Saeed, M., Suzuki, R., Watanabe, N., Masaki, T., Tomonaga, M., Muhammad, A., Kato, T., Matsuura, Y., Watanabe, H., Wakita, T., and Suzuki, T. (2011) Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitisCvirus envelope proteins and production of virus particles. J. Biol. Chem. 286, 37264-37273
27. Trujillo-Alonso, V., Maruri-Avidal, L., Arias, C. F., and López, S. (2011) Rotavirus infection induces the unfolded protein response of the cell and controls it through the nonstructural protein NSP3. J. Virol. 85, 12594-12604
28. Lawless, M. W., and Greene, C. M. (2012) Toll-like receptor signalling in liver disease: ER stress the missing link? Cytokine 59, 195-202
29. Gelderman, K. A., Hultqvist, M., Olsson, L. M., Bauer, K., Pizzolla, A., Olofsson, P., and Holmdahl, R. (2007) Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid. Redox Signal. 9, 1541-1567
30. Mieyal, J. J., and Chock, P. B. (2012) Posttranslational modification of cysteine in redox signaling and oxidative stress: focus on S-glutathionylation. Antioxid. Redox Signal. 16, 471-475
31. Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., and Shelton, M. D. (2008) Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid. Redox Signal. 10, 1941-1988
32. Shelton, M. D., and Mieyal, J. J. (2008) Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol. Cells 25, 332-346
33. Buhl, R., Jaffe, H. A., Holroyd, K. J., Wells, F. B., Mastrangeli, A., Saltini, C., Cantin, A. M., and Crystal, R. G. (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2, 1294-1298
34. Gong, G., Waris, G., Tanveer, R., and Siddiqui, A. (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-B. Proc. Natl. Acad. Sci. U.S.A. 98, 9599-9604
35. Abdalla, M. Y., Ahmad, I. M., Spitz, D. R., Schmidt, W. N., and Britigan, B. E. (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J. Med. Virol. 76, 489-497
36. Gonzalez-Dosal, R., Horan, K. A., Rahbek, S. H., Ichijo, H., Chen, Z. J., Mieyal, J. J., Hartmann, R., and Paludan, S. R. (2011)HSVinfection induces production of ROS, which potentiate signaling from pattern recognition receptors: role for S-glutathionylation of TRAF3 and 6. PLoS Pathog. 7, e1002250
37. Davis, D. A., Brown, C. A., Newcomb, F. M., Boja, E. S., Fales, H. M., Kaufman, J., Stahl, S. J., Wingfield, P., and Yarchoan, R. (2003) Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation. J. Virol. 77, 3319-3325
38. Ghezzi, P., Romines, B., Fratelli, M., Eberini, I., Gianazza, E., Casagrande, S., Laragione, T., Mengozzi, M., Herzenberg, L. A., and Herzenberg, L. A. (2002) Protein glutathionylation: coupling and uncoupling of glutathione to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol. Immunol. 38, 773-780
39. Butler, N. S., Theodossis, A., Webb, A. I., Dunstone, M. A., Nastovska, R., Ramarathinam, S. H., Rossjohn, J., Purcell, A. W., and Perlman, S. (2008) Structural and biological basis of CTL escape in coronavirus-infected mice. J. Immunol. 180, 3926-3937
40. Castro, R. F., and Perlman, S. (1995) CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69, 8127-8131
41. Pewe, L., and Perlman, S. (1999) Immune response to the immunodominant epitope of mouse hepatitis virus is polyclonal, but functionally monospecific in C57Bl/6 mice. Virology 255, 106-116
42. Anghelina, D., Pewe, L., and Perlman, S. (2006) Pathogenic role for virusspecific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am. J. Pathol. 169, 209-222
43. Anderson, M. E. (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113, 548-555
44. Griffith, O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212
45. Zhao, J., Zhao, J., and Perlman, S. (2009) De novo recruitment of antigenexperienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system. J. Immunol. 183, 5163-5170
46. Webb, A. I., Dunstone, M. A., Williamson, N. A., Price, J. D., de Kauwe, A., Chen, W., Oakley, A., Perlmutter, P., McCluskey, J., Aguilar, M. I., Rossjohn, J., and Purcell, A. W. (2005) T cell determinants incorporating β-amino acid residues are protease resistant and remain immunogenic in vivo. J. Immunol. 175, 3810-3818
47. Purcell, A. W., Gorman, J. J., Garcia-Peydró, M., Paradela, A., Burrows, S. R., Talbo, G. H., Laham, N., Peh, C. A., Reynolds, E. C., López De Castro, J. A., and McCluskey, J. (2001) Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J. Immunol. 166, 1016-1027
48. Tan, C. T., Croft, N. P., Dudek, N. L., Williamson, N. A., and Purcell, A. W. (2011) Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11, 2336-2340
49. Wu, G. F., Dandekar, A. A., Pewe, L., and Perlman, S. (2000) CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 165, 2278-2286
50. Otwinowski, Z., and Minor, W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326
51. Storoni, L. C., McCoy, A. J., and Read, R. J. (2004) Likelihood-enhanced fast rotation functions. Acta Crystallogr. D Biol. Crystallogr. 60, 432-438
52. Afonine, P. V., Grosse-Kunstleve, R. W., and Adams, P. D. (2005) A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogr. D Biol. Crystallogr. 61, 850-855
53. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132
54. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255
55. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., 3rd, Snoeyink, J., Richardson, J. S., and Richardson, D. C. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375-W383
56. Collaborative Computational Project, Number 4 (1994) The CCP4 Suite: programs for protein crystallography. Acta Crystallogr.DBiol. Crystallogr. 50, 760-763
57. Lassoued, S., Ben Ameur, R., Ayadi, W., Gargouri, B., Ben Mansour, R., and Attia, H. (2008) Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell. Biochem. 313, 179-186
58. Viswanathan, K., and Dhabhar, F. S. (2005) Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc. Natl. Acad. Sci. U.S.A. 102, 5808-5813
59. La Gruta, N. L., Kedzierska, K., Stambas, J., and Doherty, P. C. (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 85, 85-92
60. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., and Schaeffer, D. A. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell Proteomics 6, 1638-1655
61. Kim, K., Kim, S. H., Kim, J., Kim, H., and Yim, J. (2012) Glutathione Stransferase ω1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease. J. Biol. Chem. 287, 6628-6641
62. Sakai, J., Li, J., Subramanian, K. K., Mondal, S., Bajrami, B., Hattori, H., Jia, Y., Dickinson, B. C., Zhong, J., Ye, K., Chang, C. J., Ho, Y. S., Zhou, J., and Luo, H. R. (2012) Reactive oxygen species-induced actin glutathionylation controls actin dynamics in neutrophils. Immunity 37, 1037-1049
63. Bergmann, C. C., Lane, T. E., and Stohlman, S. A. (2006) Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4, 121-132
64. Perlman, S., and Dandekar, A. A. (2005) Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5, 917-927
65. Pewe, L. L., Netland, J. M., Heard, S. B., and Perlman, S. (2004) Very diverse CD8 T cell clonotypic responses after virus infections. J. Immunol. 172, 3151-3156
66. Butler, N. S., Theodossis, A., Webb, A. I., Nastovska, R., Ramarathinam, S. H., Dunstone, M. A., Rossjohn, J., Purcell, A. W., and Perlman, S. (2008) Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant. PLoS Pathog. 4, e1000186
67. Trujillo, J. A., Gras, S., Twist, K. A., Croft, N. P., Channappanavar, R., Rossjohn, J., Purcell, A. W., and Perlman, S. (2014) Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes. J. Immunol. 192, 5245-5256
68. Theodossis, A., Guillonneau, C., Welland, A., Ely, L. K., Clements, C. S., Williamson, N. A., Webb, A. I., Wilce, J. A., Mulder, R. J., Dunstone, M. A., Doherty, P. C., McCluskey, J., Purcell, A. W., Turner, S. J., and Rossjohn, J. (2010) Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc. Natl. Acad. Sci. U.S.A. 107, 5534-5539
69. Bowen, D. G., and Walker, C. M. (2005) Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709-1714
70. Goulder, P. J., and Watkins, D. I. (2004) HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4, 630-640
71. Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C., Colella, T. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., Slingluff, C. L., Jr., and Shabanowitz, J. A. (1998) Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development [published erratum appears in J. Immunol. (1999) 162, 3106]. J. Immunol. 160, 2099-2106
72. Harada, M., Gohara, R., Matsueda, S., Muto, A., Oda, T., Iwamoto, Y., and Itoh, K. (2004) In vivo evidence that peptide vaccination can induce HLADR- restricted CD4+ T cells reactive to a class I tumor peptide. J. Immunol. 172, 2659-2667
73. Campos-Perez, J., Rice, J., Escors, D., Collins, M., Paterson, A., Savelyeva, N., and Stevenson, F. K. (2013) DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1. Int. J. Cancer 133, 1400-1407
74. Meadows, L., Wang, W., den Haan, J. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., Hunt, D. F., Goulmy, E., and Engelhard, V. H. (1997) The HLA-A∗0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6, 273-281
75. Chen, W., Yewdell, J. W., Levine, R. L., and Bennink, J. R. (1999) Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J. Exp. Med. 189, 1757-1764
76. Pierce, R. A., Field, E. D., den Haan, J. M. M., Caldwell, J. A., White, F. M., Marto, J. A., Wang, W., Frost, L. M., Blokland, E., Reinhardus, C., Shabanowitz, J., Hunt, D. F., Goulmy, E., and Engelhard, V. H. (1999) Cutting edge: the HLA-A∗0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J. Immunol. 163, 6360-6364
77. Haque, M. A., Hawes, J. W., and Blum, J. S. (2001) Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. J. Immunol. 166, 4543-4551
78. Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., Burrows, S. R., Tait, B. D., Holdsworth, R., Brooks, A. G., Lovrecz, G. O., Lu, L., Rossjohn, J., and McCluskey, J. (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198, 679-691
79. Illing, P. T., Vivian, J. P., Dudek, N. L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J. J., Kjer-Nielsen, L., Gras, S., Williamson, N. A., Burrows, S. R., Purcell, A. W., Rossjohn, J., and McCluskey, J. (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486, 554-558